ArticleAnnals of the rheumatic diseases2023

Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database.

Marcin Stajszczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.